Search research articles
Contact Us
Filters
Showing results (11-20 of 38) with videos related to
Page
of 4
Sort By:
Open Forum Infectious Diseases
|
March 22, 2019
Variations in the Occurrence of Resistance Phenotypes and Carbapenemase Genes Among <i>Enterobacteriaceae</i> Isolates in 20 Years of the SENTRY Antimicrobial Surveillance Program
Mariana Castanheira, Lalitagauri M Deshpande, Rodrigo E Mendes, et al.
Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society
|
October 21, 2022
New concepts in antimicrobial resistance in cystic fibrosis respiratory infections
Pavel Drevinek, Rafael Canton, Helle Krogh Johansen, et al.
Future Microbiology
|
February 26, 2025
Cefepime-enmetazobactam: first approved cefepime-β- lactamase inhibitor combination for multi-drug resistant Enterobacterales
Tanaya Bhowmick, Rafael Canton, Federico Pea, et al.
Microbiology Spectrum
|
June 21, 2024
<i>In vitro</i> activity of cefiderocol against European Enterobacterales, including isolates resistant to meropenem and recentβ-lactam/β-lactamase inhibitor combinations
Anne Santerre Henriksen, Fabio Arena, Marie Attwood, et al.
Future Microbiology
|
May 11, 2018
Comparative in vitro antibacterial activity of ozenoxacin against Gram-positive clinical isolates
Rafael Canton, Ian Morrissey, Jordi Vila, et al.
The Journal of Antimicrobial Chemotherapy
|
November 24, 2025
Results from the Survey of Antibiotic Resistance (SOAR) 2018-21 in Italy and Spain: data based on CLSI, EUCAST (dose-specific) and pharmacokinetic/pharmacodynamic (PK/PD) breakpoints
Didem Torumkuney, Rafael Canton, Cristina Pitart, et al.
Drug Resistance Updates : Reviews and Commentaries in Antimicrobial and Anticancer Chemotherapy
|
March 29, 2011
Conserving antibiotics for the future: new ways to use old and new drugs from a pharmacokinetic and pharmacodynamic perspective
Johan W Mouton, Paul G Ambrose, Rafael Canton, et al.
Journal of Clinical Microbiology
|
September 6, 2013
Detection of colonization by carbapenemase-producing Gram-negative Bacilli in patients by use of the Xpert MDRO assay
Fred C Tenover, Rafael Canton, JoAnn Kop, et al.
Journal of Clinical Medicine
|
December 1, 2020
Impact of <i>Pseudomonas aeruginosa</i> Infection on Patients with Chronic Inflammatory Airway Diseases
Marta Garcia-Clemente, David de la Rosa, Luis Máiz, et al.
Plos One
|
May 13, 2015
High Prevalence of Co-Infections by Invasive and Non-Invasive Chlamydia trachomatis Genotypes during the Lymphogranuloma Venereum Outbreak in Spain
Mario Rodriguez-Dominguez, Jose Maria Gonzalez-Alba, Teresa Puerta, et al.
Page
of 4
Search research articles
Search
Showing results (11-20 of 38) with videos related to
Sort By:
Page
of 4
Open Forum Infectious Diseases
|
March 22, 2019
Variations in the Occurrence of Resistance Phenotypes and Carbapenemase Genes Among <i>Enterobacteriaceae</i> Isolates in 20 Years of the SENTRY Antimicrobial Surveillance Program
Mariana Castanheira, Lalitagauri M Deshpande, Rodrigo E Mendes, et al.
Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society
|
October 21, 2022
New concepts in antimicrobial resistance in cystic fibrosis respiratory infections
Pavel Drevinek, Rafael Canton, Helle Krogh Johansen, et al.
Future Microbiology
|
February 26, 2025
Cefepime-enmetazobactam: first approved cefepime-β- lactamase inhibitor combination for multi-drug resistant Enterobacterales
Tanaya Bhowmick, Rafael Canton, Federico Pea, et al.
Microbiology Spectrum
|
June 21, 2024
<i>In vitro</i> activity of cefiderocol against European Enterobacterales, including isolates resistant to meropenem and recentβ-lactam/β-lactamase inhibitor combinations
Anne Santerre Henriksen, Fabio Arena, Marie Attwood, et al.
Future Microbiology
|
May 11, 2018
Comparative in vitro antibacterial activity of ozenoxacin against Gram-positive clinical isolates
Rafael Canton, Ian Morrissey, Jordi Vila, et al.
The Journal of Antimicrobial Chemotherapy
|
November 24, 2025
Results from the Survey of Antibiotic Resistance (SOAR) 2018-21 in Italy and Spain: data based on CLSI, EUCAST (dose-specific) and pharmacokinetic/pharmacodynamic (PK/PD) breakpoints
Didem Torumkuney, Rafael Canton, Cristina Pitart, et al.
Drug Resistance Updates : Reviews and Commentaries in Antimicrobial and Anticancer Chemotherapy
|
March 29, 2011
Conserving antibiotics for the future: new ways to use old and new drugs from a pharmacokinetic and pharmacodynamic perspective
Johan W Mouton, Paul G Ambrose, Rafael Canton, et al.
Journal of Clinical Microbiology
|
September 6, 2013
Detection of colonization by carbapenemase-producing Gram-negative Bacilli in patients by use of the Xpert MDRO assay
Fred C Tenover, Rafael Canton, JoAnn Kop, et al.
Journal of Clinical Medicine
|
December 1, 2020
Impact of <i>Pseudomonas aeruginosa</i> Infection on Patients with Chronic Inflammatory Airway Diseases
Marta Garcia-Clemente, David de la Rosa, Luis Máiz, et al.
Plos One
|
May 13, 2015
High Prevalence of Co-Infections by Invasive and Non-Invasive Chlamydia trachomatis Genotypes during the Lymphogranuloma Venereum Outbreak in Spain
Mario Rodriguez-Dominguez, Jose Maria Gonzalez-Alba, Teresa Puerta, et al.
Page
of 4